Publication | Closed Access
Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adults
20
Citations
8
References
2014
Year
Drug SafetyPost-exposure ProphylaxisPreventive MedicineAllergyThree-dose Biothrax® RegimenClinical TrialsPharmacotherapyInfection ControlImmunotherapyMedicinePhase 3
| Year | Citations | |
|---|---|---|
Page 1
Page 1